Track Order   | Customer Support   | Request Book   |
International Order
Clinical Applications Of Continuous Infusion Chemotherapy And Concomitant Radiation Therapy at Meripustak

Clinical Applications Of Continuous Infusion Chemotherapy And Concomitant Radiation Therapy

Books from same Author: C. Julian Rosenthal , Marvin Rotman

Books from same Publisher: Kluwer Academic Publishers Group

Related Category: Author List / Publisher List

  • Retail Price: ₹ 10092/- [ 0.00% off ]

    Seller Price: ₹ 10092

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 0.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 0.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available


Click for International Orders
  • Provide Fastest Delivery
  • 100% Original Guaranteed
    • General Information  
    Author(s)C. Julian Rosenthal , Marvin Rotman
    PublisherKluwer Academic Publishers Group
    ISBN9780306422607
    Pages261
    BindingHardback
    LanguageEnglish
    Publish YearOctober 1986

    Description

    Kluwer Academic Publishers Group Clinical Applications Of Continuous Infusion Chemotherapy And Concomitant Radiation Therapy by C. Julian Rosenthal , Marvin Rotman

    The First Conference On Concomitant Infusion Chemotherapy And Radia- Tion Therapy Was Organized With The Intention Of Bringing Together Some Of The Investigators Who Have Tested During The Last Few Years The Hypo- Thesis That Continuous Infusion Chemotherapy Could Modulate The Cytotoxic Effect Of Radiation Therapy To The Point Of Having A Strongly Additive If Not Synergistic Activity On Certain Malignant Tumors. This Volume Represents The Detailed Proceedings Of This Conference Presented In A Way That Offers The Reader A Review Of The On-Going Re- Search In The Field. We Have Stressed A Number Of Subjects From Basic Biologic Research And Influence Of Cell Kinetics To The Practical Methods Of Drug Delivery Systems And Early Clinical Experiences. The Rationale For This New Type Of Combined Modality Therapy Has Been Presented By Some Of Its Pioneers. Early Clinical Investigations As Well As The Preliminary Data Of Many That Have Not Yet Completely Matured Have Also Been Included. The Reader Should Look At These Data With Some Reser- Vations.Ultimately These Results Must Be Confirmed By Larger Prospective Randomized Studies With Proper Controls Before Becoming Accepted As The Treatment Of Choice In Locally Advanced Tumors.